FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported a loss of $4.17 billion in its first quarter.
The Foster City, California-based company said it had a loss of $3.34 per share. Losses, adjusted for asset impairment costs and costs related to mergers and acquisitions, were $1.32 per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.49 per share.
The HIV and hepatitis C drugmaker posted revenue of $6.69 billion in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $6.33 billion.
Gilead expects full-year earnings in the range of $3.45 to $3.85 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
